Evidence map›Paper›PMID 20139218›Full record

Trial reportBMJ (Clinical research ed.)2010

Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial.

David Turner, Paul Little, James Raftery, Sheila Turner, Helen Smith, Kate Rumsby, Mark Mullee, UTIS group

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Screening with urinary dipsticks for reducing morbidity and mortality.The Cochrane database of systematic reviews · 2015
    Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Observational
  16. Top 10 Self Learning articles from 2017.Canadian family physician Medecin de famille canadien · 2019
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

David TurnerWessex Institute, University of Southampton, Alpha House, Southampton Science Park, Chilworth, Southampton SO16 7NS. dturner@soton.ac.uk
Paul Little
James Raftery
Sheila Turner
Helen Smith
Kate Rumsby
Mark Mullee
UTIS group

Funding

Department of Health 97/14/06
6 · The paper itself

Abstract

objectiveTo assess the cost effectiveness of different management strategies for urinary tract infections.

designCost effectiveness analysis alongside a randomised controlled trial with a one month follow-up.

settingPrimary care.

participants309 non-pregnant adult women aged 18-70 presenting with suspected urinary tract infection.

interventionsPatients were randomised to five basic management approaches: empirical antibiotics, empirical delayed (by 48 hours) antibiotics, or targeted antibiotics based on either a high symptom score (two or more of urine cloudiness, smell, nocturia, dysuria), dipstick results (nitrite or leucocytes and blood), or receipt of a positive result on midstream urine analysis.

main outcome measureDuration of symptoms and cost of care.

resultsManagement with targeted antibiotics with midstream urine analysis was more costly over the period of one month. Costs for the midstream urine analysis and dipstick management groups were pound37 and pound35, respectively; these compared with pound31 for immediate antibiotics. Cost effectiveness acceptability curves suggested that if avoiding a day of moderately bad symptoms was valued at less than pound10, then immediate antibiotics is likely to be the most cost effective strategy. For values over pound10, targeted antibiotics with dipstick testing becomes the most cost effective strategy, though because of the uncertainty we can never be more than 70% certain that this strategy truly is the most cost effective.

conclusionDipstick testing with targeted antibiotics is likely to be cost effective if the value of saving a day of moderately bad symptoms is pound10 or more, but caution is required given the considerable uncertainty surrounding the estimates.

Indexed as

AdolescentAdultAgedAnti-Bacterial AgentsAnti-Infective Agents, UrinaryCost-Benefit AnalysisFemaleHumansMaleMiddle AgedReagent Kits, DiagnosticTreatment OutcomeUrinary Tract InfectionsYoung AdultAnti-Bacterial AgentsAnti-Infective Agents, UrinaryReagent Kits, Diagnostic

Identifiers

PMID20139218
PMCPMC2817048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.